Candel Therapeutics, Inc.CADLNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-38.90M
↓ 57% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-24.76M
Historical baseline
PeriodValueYoY Change
2025$-38.90M-43.9%
2024$-27.04M+22.1%
2023$-34.70M-6.1%
2022$-32.72M-36.0%
2021$-24.05M-128.1%
2020$-10.55M-97.7%
2019$-5.34M-